Drug intelligence / Profile preview

Chinese Academy of Medical Sciences and Peking Union Medical College Pin1 compound 4a

Development stage
Unknown
Lead developer
Chinese Academy of Medical Sciences and Peking Union Medical College
01

Overview

Chinese Academy of Medical Sciences and Peking Union Medical College Pin1 compound 4a: sourced facts only. name: "Herein, a series of sulfolane amino-substituted 2-chloro-5-nitropyrimidine derivatives were disclosed as structurally distinct covalent inhibitors toward Pin1, which were validated for their covalent binding to Cys113 of Pin1 by X-ray cocrystal structures of compounds 4a (IC50 = 11.55 μM) and 6a (IC50 = 3.15 μM)." [PMID:39811131]; target: "Herein, a series of sulfolane amino-substituted 2-chloro-5-nitropyrimidine derivatives were disclosed as structurally distinct covalent inhibitors toward Pin1, which were validated for their covalent binding to Cys113 of Pin1 by X-ray cocrystal structures of compounds 4a (IC50 = 11.55 μM) and 6a (IC50 = 3.15 μM)." [PMID:39811131]; developer: "Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China." [PMID:39811131]

02

Targets

PIN1 (Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1)

Beyond the preview

Go deeper on Chinese Academy of Medical Sciences and Peking Union Medical College Pin1 compound 4a.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chinese Academy of Medical Sciences and Peking Union Medical College Pin1 compound 4a.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call